Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway

Details for Australian Patent Application No. 2005294265 (hide)

Owner University of Rochester

Inventors White, R. James; Taubman, Mark B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005294265

PCT Pub. Number WO2006/042017

Priority 60/616,567 06.10.04 US

Filing date 6 October 2005

Wipo publication date 20 April 2006

International Classifications

A61K 38/54 (2006.01) Medicinal preparations containing peptides

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/042017 Priority application(s): WO2006/042017

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294269-Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

2005294258-Method for the treatment of polycystic kidney disease